Where can I find the results of Novartis clinical trials?
Where can I find the results of Novartis clinical trials?
The results of Novartis clinical trials are made publicly available through peer-reviewed publications and posting of results on the Novartis clinical trial results database and other online public databases.
How is Novartis helping to improve the environment?
While Novartis Group sales have increased in the past 10 years, our consumption of energy and water, as well as our greenhouse gas emissions, have declined. Carbon neutral in our operations by 2025. Our climate targets meet the criteria of the Science Based Targets Initiative. Water neutral in all areas of our operations by 2030.
Where is the headquarters of Novartis in Switzerland?
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
What does the Information Center at Novartis do?
The information center provides a central hub for news, guidance and resources. Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach. Novartis aims to report comprehensively and transparently about ESG topics.
What kind of cancer does Novartis care for?
At Novartis, we focus on five key cancer areas where we have identified patient needs and promise within our portfolio – breast cancer, lung cancer, melanoma, kidney cancer and hematology. Learn about AI in cancer research. Our scientists are breaking through the barriers to transform cancer care and reimagine medicine.
What was the result of the Novartis scandal?
The failure to report the issue has not put patients at risk, the F.D.A. said, but the drugmaker could face criminal and civil penalties. A branch of the Swiss drugmaker Novartis.
When did Novartis find out about data manipulation?
The F.D.A. said it was notified of the data manipulation issue on June 28, more than one month after Zolgensma was approved, even though officials at AveXis, the Novartis unit developing the product, learned of the problem in March. The problems involved experiments on mice used in early phases of the research.